Role of cystic fibrosis transmembrane conductance regulator in patients with chronic sinopulmonary disease.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Chest

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/chest.11-2543PMID 22423042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendations for the classification of diseases as CFTR-related disorders.

  2011cited by this paper
• Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.

  2010cited by this paper
• High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program.

  2010cited by this paper
• Mutations of the cystic fibrosis gene in patients with bronchiectasis associated with rheumatoid arthritis

  2010cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Does the Macroduct collection system reliably define sweat chloride concentration in subjects with intermediate results?

  2009cited by this paper
• Cystic fibrosis

  2009cited by this paper
• Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.

  2008cited by this paper
• Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

  2008cited by this paper
• Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

  2008cited by this paper
• 17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia.

  2008cited by this paper
• Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials.

  2006cited by this paper
• Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers.

  2006cited by this paper
• Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines.

  2006cited by this paper
• Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.

  2006cited by this paper
• The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis

  2005cited by this paper
• Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis.

  2004cited by this paper
• Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign.

  2004cited by this paper
• Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations?

  2004cited by this paper
• Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy.

  2003cited by this paper
• Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

  2003cited by this paper
• High frequency of T9 and CFTR mutations in children with idiopathic bronchiectasis

  2003cited by this paper
• Improved survival among young patients with cystic fibrosis.

  2003cited by this paper
• The impact of early cystic fibrosis diagnosis on pulmonary function in children.

  2002cited by this paper
• CFTR mutation detection by multiplex heteroduplex (mHET) analysis on MDE gel.

  2002cited by this paper
• Bronchial inflammation and colonization in patients with clinically stable bronchiectasis.

  2001cited by this paper
• An investigation into causative factors in patients with bronchiectasis.

  2000cited by this paper
• Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population.

  2000cited by this paper
• Spirometric reference values from a sample of the general U.S. population.

  1999cited by this paper
• CFTR Gene Mutations in Adults with Disseminated Bronchiectasis

  1997cited by this paper
• Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis.

  1997cited by this paper
• Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis.

  1995cited by this paper
• In Vivo Nasal Potential Difference: Techniques and Protocols for Assessing Efficacy of Gene Transfer in Cystic Fibrosis

  1995cited by this paper
• Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis.

  1994cited by this paper
• Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA

  1993cited by this paper
• Cystic fibrosis: scoring system with thin-section CT.

  1991cited by this paper
• Plasma Immunoreactive Pancreatic Cationic Trypsinogen in Cystic Fibrosis: a Sensitive Indicator of Exocrine Pancreatic Dysfunction

  1981cited by this paper
• A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

  1959cited by this paper

• Progressive Pulmonary Lesion due to Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction: A Case Study From Japan

  2025cites this paper
• Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients

  2025cites this paper
• ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.

  2024cites this paper
• Assessing accuracy of testing and diagnosis in cystic fibrosis

  2023cites this paper
• Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators

  2023cites this paper
• ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria.

  2022cites this paper
• ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction.

  2022cites this paper
• Chloride channels in the lung: Challenges and perspectives for viral infections, pulmonary arterial hypertension, and chystic fibrosis.

  2022cites this paper
• Journal of Cystic Fibrosis

  2022cites this paper
• The CFTR Mutation c.3453G > C (D1152H) Confers an Anion Selectivity Defect in Primary Airway Tissue that Can be Rescued by Ivacaftor

  2020cites this paper
• Papel do CFTR nas doenças respiratórias : possibilidade de novas abordagens terapêuticas

  2017cites this paper
• Molecular Genetics of Cystic Fibrosis Transmembrane Conductance Regulator: Genotype and Phenotype.

  2016cites this paper
• Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?

  2015cites this paper
• Cystic fibrosis

  2015cites this paper
• Inhaled Antibiotics in Cystic Fibrosis (CF) and Non-CF Bronchiectasis

  2015cites this paper
• Newborn screening for cystic fibrosis

  2015cites this paper
• Fungi in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis

  2015cites this paper
• Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?

  2014cites this paper
• Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case–control study

  2014cites this paper
• CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy: Report on the pre-conference meeting to the 11th ECFS Basic Science Conference, Malta, 26-29 March 2014.

  2014cites this paper
• A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor

  2014cites this paper
• Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?

  2013cites this paper
• Role of Cystic Fibrosis Transmembrane Conductance Regulator in Patients With Chronic Sinopulmonary Disease

  2013cites this paper
• Characterization of SLC26A9 in Patients with CF‐Like Lung Disease

  2013cites this paper
• Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.

  2012cites this paper
• Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language?

  2012cites this paper
• β-adrenergic sweat secretion as a diagnostic test for cystic fibrosis.

  2012cites this paper